Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.41%
#3 Cysic Cysic +17.50%
#4 Bedrock Bedrock +11.95%
#5 Fabric Protocol Fabric Protocol +8.04%
#6 stake.link stake.link +7.65%
#7 Cap Cap +6.89%
#8 DUSK Network DUSK Network +5.71%
#9 Pons Pons +5.51%
#10 FOLKS FOLKS +5.24%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
BerGenBio ASA BerGenBio ASA

BerGenBio ASA

BGBIO
Rang in aandelen #37880
BerGenBio ASA is a biopharmaceutical firm in the clinical development stage,... BerGenBio ASA is a biopharmaceutical firm in the clinical development stage, focused on developing therapies for drug-resistant, immune-evasive, and metastatic cancers, in addition to respiratory conditions. Its leading compound, Bemcentinib, is a bio-available small molecule AXL inhibitor currently in Phase II clinical trials for major cancer indications and COVID-19. The Phase II trial program specifically addresses non-small cell lung cancer, acute myeloid leukemia, myelodysplastic syndrome, and COVID-19. Moreover, the company is progressing tilvestamab, an anti-AXL antibody, through Phase Ib clinical trials. BerGenBio ASA also maintains a collaboration agreement with Merck & Co. for its clinical studies. The company was founded in 2007 and operates from its base in Bergen, Norway.
Aandeelprijs
$0.051239
Laatst gesynchroniseerd: 2025-11-24
Marktkapitalisatie
$1.38M
Verandering (1 dag)
-4.48%
Verandering (1 jaar)
-54.57%
Land
NO
Handel BerGenBio ASA (BGBIO)

Categorie

Healthcare
Aandelsplitsingen voor BerGenBio ASA (BGBIO)
Het aandeel BerGenBio ASA (symbool: BGBIO) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 15, 2026.
Eén aandeel BGBIO dat vóór Aug 15, 2026 werd gekocht, staat nu gelijk aan 0 aandelen BGBIO.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE